Non-Hodgkin's Lymphoma: Current Strategies, Ongoing Challenges, and Future Treatments in Follicular Lymphoma

Autor: Faculty : Steven Horwitz, MD. Associate Attending
Contribuidor de contenido: Memorial Sloan Kettering Cancer Center, New York, NY
Fecha de la última revisión: May 03, 2013

Non-Hodgkin's lymphoma (NHL) is the most common hematologic malignancy in adults, and the sixth most common cancer diagnosed in the United States each year. Upon completion of this activity, participants will be able to: 1)Review recent revisions to NHL treatment guidelines, including updated therapy algorithms, 2) Review the complications associated with treating patients with NHL, and 3) Review the most current data about new therapies, treatment strategies, and combination regimens for NHL.

Continue to Activity

Blogs

May 31, 2023

A Poet’s Autobiography of Cancer

by OncoLink Team


September 16, 2022

Wine Racks and the Mystery of Survival

by Rodney Warner, JD


July 26, 2022

Fear

by Rodney Warner, JD